By proceeding, you agree to our Terms of Use and Privacy Policy.
Anjali Pandey is currently SVP, NonClinical R&D and Chemistry at ARIA Pharmaceuticals ( Formerly twoXAR Pharmaceuticals)
Talks About #drugdiscovery #pharma
Preferred Locations #NorthAmerica
Welcome to the 6th Obesity & NASH Drug Development Summit There has been a rise and fall of investment in NASH in the wake of highly demanding biopsy endpoints and late-stage clinical setbacks.